The use of talcum powder for feminine hygiene has been found to cause ovarian cancer, and women around the nation are filing talcum powder cancer claims against Johnson & Johnson. In two landmark cases during 2016, this law firm won $72 million and $55 million in damages on behalf of women who suffered from ovarian cancer after using Johnson's Baby Powder routinely. These are the first two cases that have resulted in monetary compensation to resolve baby powder cancer claims.
Evidence presented in these lawsuits indicates Johnson & Johnson officials have intentionally concealed talcum powder cancer risk information from consumers over the course of decades. Furthermore, company records indicate baby powder marketing has been particularly directed at African-American and Hispanic women. Once a trusted household name for family-oriented health and cosmetic products, Johnson and Johnson has lost Americans' trust in recent years. J&J has been forced to issue recalls for major products such as Tylenol, DePuy hip replacement parts, and Bausch and Lomb contact lenses; now the company faces more than a thousand pending talcum powder cancer lawsuits.
Dr. Daniel Cramer, a Harvard epidemiologist, estimates that 10,000 American women develop ovarian cancer each year as a result of using talcum powder for perineal dusting. Ovarian cancer causes approximately 14,000 deaths each year among American women. Research dating back to the 1980s has documented the connection between baby powder and ovarian cancer.
Women and the family members of women who have suffered from ovarian cancer after using talcum powder, such as Johnson's Baby Powder, or a talc-based body freshener, such as Shower to Shower, may have grounds to file a baby powder lawsuit. Filing a claim allows a woman and her family to seek compensation for the pain, suffering, medical expenses and loss associated with ovarian cancer. This website provides access to comprehensive legal services from the nation's leading talcum powder ovarian cancer attorneys.
Women and the family members of women who have suffered from ovarian cancer and have a history of using talcum powder may be eligible to file a claim against Johnson & Johnson. The leading producer of talc-based body powders and fresheners, Johnson & Johnson has neglected to warn consumers of longstanding research linking baby powder to ovarian cancer. Read full talcum powder cancer lawsuit
These attorneys have a track record of winning large settlements in talcum powder cancer lawsuits. On this page, they have answered the most common questions received about filing a baby powder claim such as, How much does it cost to file a talcum powder lawsuit? For answers to your specific questions, please contact the firm for a free, no-obligation consultation. Read answers to Talcum Powder Lawsuit FAQs
Having won the first two baby powder lawsuit awards in the United States, these attorneys are the national leaders on talcum powder cancer litigation. Aware of the very serious nature of talcum powder cancer claims, these attorneys are committed to seeking justice no matter how complicated the case. These attorneys work on a contingency basis, meaning there are no fees unless we collect for you. Read full ovarian cancer lawsuit information from national talcum powder cancer lawyers
While Johnson has outwardly denied the talcum powder ovarian cancer risk, company officials have known for decades of the research linking baby powder to ovarian cancer. Numerous studies dating back to the 1970s have concluded that talc particles which reach the ovaries increase a woman's risk of ovarian cancer. Read for full talcum powder ovarian cancer risk
Because talcum powder is classified as a cosmetic, no FDA talcum powder cancer warning has ever been issued. Talcum powder is intended for external use, but researchers have found that through routine perineal dusting, talc particles may travel through the female reproductive system and come to rest in the ovaries. Many organizations have issued ovarian cancer warnings regarding baby powder. Read full talcum powder cancer warning
The Talcum Powder Cancer Timeline
Baby Powder Cancer Research Emerges
- 1971: A study published by Dr. Henderson showed the first evidence of a link between talcum powder an cancer.
- 1982: Dr. Cramer's epidemiologic study is the first to look at the risk in a pointed fashion. Cramer concluded talc use could increase a woman's chance of developing ovarian cancer by 92%. The release of this study earned Dr. Cramer a visit from Dr. Bruce Semple, an employee of Johnson & Johnson. Dr. Semple urged Cramer to down play the risk of ovarian cancer from talcum powder dusting of the perineum. Dr. Cramer countered by urging Johnson & Johnson to warn consumers of the risk.
- Since 1982, more than 20 epidemiological studies have produced evidence documenting an increased risk for ovarian cancer from talcum powder use. Evidence presented to the jury indicates J&J and other industry officials were aware of the studies as they were published.
J&J Develops a Strategy to Conceal the Risk of Baby Powder Cancer
- 1986: A Johnson & Johnson "Technological Forecast" - an internal company document - describes talc as without health benefits. The company acknowledged, internally, that the safety of talcum powder was in question and that the health benefits of talcum powder were unknown.
- 1992: In response to declining sales of talc-based body products such as Johnson's Baby Powder and Shower to Shower, J&J officials launch a marketing campaign directed at African American and Hispanic women in order to increase sales among those populations.
- Shortly thereafter, J&J joins the newly formed "Talc Interested Party Task Force". Comprised of representatives from the cosmetic and manufacturing industries, the task force sets out to create a "defense strategy" to keep talc unregulated.
- 1994: Dr. Samuel Epstein of the Cancer Prevention Coalition appeals to J&J to withdraw talcum powder products or, at a minimum, warn consumers of the link between perineal dusting with talcum powder and ovarian cancer development.
Numerous Companies Stop Using Talc for Internal Use
- 1995: Condom industry voluntary stops using talcum powder to dust its products, due to increasing evidence indicating talcum powder causes ovarian cancer.
- 1997: Internal company memos show employees within Johnson & Johnson are not in agreement about the appropriate course of action for responding to the talcum powder cancer risk. Dr. Wehner, the company's head toxicologist, wrote to Michael Chudkowski, the manager of preclinical toxicology, addressing concerns that the company was publicly lying about the safety of talcum powder for perneal dusting. This exchange is pivotal, because Wehner compares J&J's actions to the tobacco industry's denial of the obvious risk of lung cancer from smoking.
- 1998: Many internal documents have revealed the companies involved were internally strategizing for a fight against the talcum powder cancer risk while publicly acting as if nothing was happening. There is a characteristic document from 1998 where Luzenac (talc manufacturer) requested that scientists "from the club" - those on the talc industry's side - be brought in to oppose the classification of talc as carcinogenic.
- 1998: Quietly, without fanfare, a subsidiary of Johnson & Johnson - Janssen Pharmaceuticals - changed the contents of its diaphragm labels, omitting an instruction to use talcum powder on the product. Similar to the cessation of talc being used in the condom industry, this quiet action speaks volumes, indicating the company was cognizant of the risk posed to women by talcum powder.
J&J's Talc Supplier Concedes to the Baby Powder Cancer Risk
- 2002: Luzenac formally initiates a strategy for responding to product liability litigation for talcum powder. Simultaneously, the companies continue to fight to classification of talc as a carcinogen by various health organizations.
- 2005: The World Health Organization's International Agency for Research on Cancer (IARC) votes to classify talc as a 2B carcinogen, stating the product is a possible carcinogen based on consistent research on the talcum powder cancer risk.
- 2006: Luzenac, the talc mining company that supplies raw talc to J&J factories, begins stamping its product with a talc cancer warning. Johnson & Johnson has still never warned consumers of the potential risk.